Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschoolers
NCT06761092Phase 4Active, not recruiting
- Sponsor
- Udayana University
- Start
- Dec 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in emergence delirium (ED) comparing Nebulized Dexmedetomidine with Placebo (2 arms). Primary endpoint: Incidence of Post-Anesthesia Delirium at 120 minutes. Started Dec 2024; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT06761092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06761092.